Exenatide QW significantly improved HbA1c reductions vs exenatide BID at 30 weeks
Authors
Drucker et al
EndoBarrier in 90 consecutively treated patients - Abstract
EndoBarrier treatment for longstanding type 2 diabetes and obesity: outcomes one year after EndoBarr
Meta-analysis
Covid-19 Meta-analysis